Surgical Site Infections Following Bariatric Surgery in Community Hospitals: A Weighty Concern?
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Although obesity is a well-known risk factor for surgical site infection (SSI), specific risk factors for SSI among obese patients undergoing bariatric surgery (BS) have not been well-defined.
We performed a prospective cohort study on patients who underwent BS at nine community hospitals in the USA between 7/1/2007 and 12/31/2008. Each patient had the following data recorded: National Nosocomial Infection Surveillance (NNIS) risk index; the choice, timing, and dose of antibiotic prophylaxis; age; body mass index; and duration of surgery. NNIS criteria were used to define SSI. Cases were detected during the post-operative hospital stay, on readmission to hospital within 30 days of the procedure and by post-discharge surveillance.
A total of 2,012 patients were included in the study. The majority of procedures were laparoscopic (82%). The overall rate of SSI was 1.4% (28/2012). Patients who received vancomycin surgical prophylaxis were more likely to develop SSI than patients who received other antibiotics (relative risk [RR] = 9.4; 95% confidence interval [CI] = 3.1–26.1; p = 0.005). More specifically, patients who received vancomycin prophylaxis as a single agent at a dose less than 2 g were more likely to develop SSI than patients who received other antibiotic regimens (RR = 7.1; 95% CI = 1.9–23.8; p = 0.035).
Inadequate dosing of vancomycin prophylaxis prior to BS is associated with increased risk of SSI. If vancomycin is used for prophylaxis, the appropriate dose should be calculated using actual bodyweight rather than lean bodyweight in accordance with Infectious Disease Society of America recommendations.
- Olsen MA, Nepple JJ, Riew KD, et al. Risk factors for surgical site infection following orthopaedic spinal operations. J Bone Joint Surg Am. 2008;90:62–9. CrossRef
- Dindo D, Muller MK, Weber M, et al. Obesity in general elective surgery. Lancet. 2003;361:2183–9. CrossRef
- Flancbaum L, Choban PS. Surgical implications of obesity. Ann Rev Med. 1998;29:215–34. CrossRef
- Nguyen NT, Goldman C, Rosenquist CJ, et al. Laparoscopic versus open gastric bypass: a randomized study of outcomes, quality of life and costs. Ann Surg. 2001;234:279–89. CrossRef
- Christou NV, Jarand J, Sylvestre JL, et al. Analysis of the incidence and risk factors for wound infections in open bariatric surgery. Obes Surg. 2004;14:16–22. CrossRef
- National Nosocomial Infections Surveillance (NNIS) System Report. Data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control. 2004;32:470–85. CrossRef
- Smoot TM, Hilsenrath P, Kuppersmith NC, et al. Gastric bypass surgery in the United States, 1998–2002. Am J Public Health. 2006;96:1187–9. CrossRef
- Mangram AJ, Horan TC, Pearson ML, et al. Hospital Infection Control Practice Advisory Committee. Guideline for prevention of surgical site infection. Infect Control Hosp Epidemiol. 1999;20:247–78. CrossRef
- Emori TG, Culver DH, Horan TC, et al. National nosocomial infections surveillance system (NNIS): description of surveillance methods. M J Infect Control. 1991;19:19–35. CrossRef
- The Longitudinal Assessment of Bariatric Surgery (LABS) Consortium. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med. 2009;361:445–54. CrossRef
- Culver DH, Horan TC, Gaynes RP, et al. Surgical wound infection rates by wound class, operative procedure, and patient risk index. National Nosocomial Infections Surveillance System. Am J Med. 1991;91:152S–7S. CrossRef
- Carrier M, Marchand R, Anger P, et al. MRSA infection in a cardiac surgical unit. J Thorac Cardiovasc Surg. 2002;123:40–4. CrossRef
- Anderson DJ, Kaye KS. Staphylococcal surgical site infections. Infect Dis Clin North Am. 2009;23:53–72. CrossRef
- Kellum JM, DeMaria EJ, Sugerman HJ. The surgical treatment of morbid obesity. Curr Probl Surg. 1998;35:791–858. CrossRef
- Trinh JV, Chen LF, Sexton DJ, et al. Risk factors for gram negative bacterial surgical site infection: do allergies to antibiotics increase risk? Infect Control Hosp Epidemiol. 2009;30:440–6. CrossRef
- Vance-Bryan K, Guay DR, Gilliland SS, et al. Effect of obesity on vancomycin pharmacokinetic parameters as determined by using a Bayesian forecasting technique. Antimicrob Agents Chemother. 1993;37:436–40.
- Hall RG, Payne KD, Bain AM, et al. Multicenter evaluation of vancomycin dosing: emphasis on obesity. Am J Med. 2008;121:515–8. CrossRef
- Pai MP, Bearden DT. Antimicrobial dosing considerations in obese adult patients. Pharmacotherapy. 2007;27:1081–91. CrossRef
- Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004;39:1267–84. CrossRef
- Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis. 2005;41:1373–406. CrossRef
- Bonten MJ, Chastre J, Craig WA, et al. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia Am J Respir Crit Care Med. 2005;171:388–416.
- Surgical Site Infections Following Bariatric Surgery in Community Hospitals: A Weighty Concern?
Volume 21, Issue 7 , pp 836-840
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Surgical site infection
- Vancomycin dosing
- Bariatric surgery
- Industry Sectors
- Author Affiliations
- 1. Duke Infection Control Outreach Network (DICON), Duke University Medical Center, DUMC 3605, Durham, NC, 27710, USA
- 3. Department of Clinical Microbiology, Auckland City Hospital, Auckland, New Zealand
- 2. Division of Surgery, Duke University Medical Center, Durham, NC, 27710, USA